BioCentury
ARTICLE | Clinical News

Somatoprim: Phase IIa data

April 8, 2013 7:00 AM UTC

Top-line data from an open-label, Ukrainian Phase IIa trial in about 20 treatment-naïve patients with acromegaly showed that single ascending-doses of subcutaneous Somatoprim dose-dependently reduced ...